Back to companies

Bausch Health Companies Inc: Overview

Bausch Health Companies Inc (Bausch Health), formerly Valeant Pharmaceuticals International Inc, is engaged in the manufacturing, development, and marketing of a range of medical devices, over-the-counter products (OTC), and pharmaceutical products. Bausch Health offers products for therapy areas related to dermatology, gastroenterology, eye health, neurology, aesthetic devices, dentistry, and consumer health. It offers various generic and branded generic products. Bausch Health has administrative, research and laboratory, marketing, distribution, and warehousing facilities worldwide. The company offers products directly or indirectly in various regions across the world including the US, Canada, Africa, Middle East, Australia, Latin America, and Europe. It also operates manufacturing facilities in the US, Brazil, Columbia, Germany, Canada, among others. Bausch Health is headquartered in Laval, Quebec, Canada.

Headquarters Canada

Address 2150 Saint-Elzear Blvd W, Laval, Quebec, H7L4A8


Telephone 1 514 7446792

No of Employees 19,600

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange BHC (TSE)

Revenue (2022) $8.4B 5.1% (2022 vs 2021)

EPS XXX

Net Income (2022) XXX -69.3% (2022 vs 2021)

Market Cap* $2.8B

Net Profit Margin (2022) XXX -61.0% (2022 vs 2021)

* As of and is in US$

Access premium data and analytics for Bausch Health Companies Inc

640+

Clinical Trials

Determine Bausch Health Companies Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

570+

Marketed Drugs

Understand Bausch Health Companies Inc’s commercialized product portfolio to stay one step ahead of the market.

150+

Catalyst Calendar

Proactively evaluate Bausch Health Companies Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

130+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

100+

Pipeline Drugs

Identify which of Bausch Health Companies Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

90+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Bausch Health Companies Inc’s relevant decision makers and contact details.

70+

Sales & Consensus Forecasts

Understand the current and future drug revenue for Bausch Health Companies Inc and assess market opportunity for new entrants with patient population 8-year forecasts.

30+

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

1

Investigators

Review investigator profiles and find information on trial contacts across Bausch Health Companies Inc, including performance indicators like number of completed trials, and linked attributes such as rehiring statistics.

260+

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

200+

Medical Marketed Products

A database of medical devices currently for sale around the world. Devices that have been approved by a regulatory authority are included.

200+

Install Base

Install Base provides a holistic and a granular view of the IT product/service deployments from leading vendors. Explore IT infrastructure categories, solution and product/service areas deployed by a prospect.

80+

Consumer Market Data Insights

Gain insights from product sales across markets, product categories and channels. Get intelligence on market shares, retail sales footprint, market position and strength for consumer segments and geographies.

60+

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

3

IT Services Contracts

Improve competitive bidding with insights into all publicly disclosed IT services contracts for Bausch Health Companies Inc (including IT outsourcing, business process outsourcing, systems integration & consulting and more).

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Bausch Health Companies Inc’s likely spend across technology areas enabling you to understand the digital strategy.

Subscribe to Company Analytics & gain access to premium industry data & analytics Subscribe to Company Analytics & gain access to premium industry data & analytics Start Here

Products and Services

Products Brands
Dermatological Aergel
Atopic Dermatitis Akreos
Psoriasis, Acitinic Keratosis Alaway
XXX XXX
XXX XXX
XXX XXX
Subscribe to Company Analytics for access to more products & services data Subscribe to Company Analytics for access to more products & services data Learn More

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2022 Others In October, the company and Salix Pharmaceuticals announced the endorsement of the implementation of K76.82, an ICD-10 code from the Centers for Medicare & Medicaid Services for hepatic encephalopathy.
2022 Regulatory Approval In September, the company and Glenmark Specialty secured approval from Health Canada for its RYALTRIS in Canada.
2022 Regulatory Approval In September, the company and its gastroenterology business Salix Pharmaceuticals responded to the U.S. Food and Drug Administration's (FDA) tentative approval of the Norwich Pharmaceuticals rifaximin 200 mg product.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Get Started
Image for loader

Competitor Comparison

Key Parameters Bausch Health Companies Inc Novartis AG Merck & Co Inc Sanofi Viatris Inc
Headquarters Canada Switzerland United States of America France United States of America
City Laval Basel Kenilworth Paris Canonsburg
State/Province Quebec - New Jersey - Pennsylvania
No. of Employees 19,600 108,000 68,000 95,442 37,000
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Joseph C. Papa Chairman Executive Board 2022 -
Thomas J. Appio Chief Executive Officer Senior Management 2022 -
Sam Eldessouky Chief Financial Officer; Executive Vice President Senior Management 2021 -
Frederick J. Munsch Chief Accounting Officer; Senior Vice President; Controller Senior Management 2021 -
Tage Ramakrishna, M.D. President - R&D; Chief Medical Officer Senior Management 2011 -
Non Dignissim Eros Proin vel Convallis 2023 XX
Non Dignissim Eros Proin vel Convallis 2023 XX
Non Dignissim Eros Proin vel Convallis 2023 XX
Gain more insight into company management & employee structure with Company Analytics Gain more insight into company management & employee structure with Company Analytics Subscribe
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company Analytics

Contact the team or request a demo to find out how our data can drive your business forward

Why are you leaving?